Listed

Surrozen, Inc.

SRZNNasdaqCIK 1824893HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$5.0m, Q2 FY2026
Operating income−$10.4m, Q2 FY2026
Net income$50.2m, Q2 FY2026
Surrozen, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0000950170-25-047712. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure10.0Revenue, Q3 FY2024, three months to 2024-09-30$10.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure0.7Revenue, Q4 FY2024, three months to 2024-12-31$655.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure1.0Revenue, Q1 FY2025, three months to 2025-03-31$983.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure1.0Revenue, Q2 FY2025, three months to 2025-06-30$983.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure1.0Revenue, Q3 FY2025, three months to 2025-09-30$983.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure0.5Revenue, Q4 FY2025, three months to 2025-12-31$528.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure5.0Revenue, Q1 FY2026, three months to 2026-03-31$5.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure5.0Revenue, Q2 FY2026, three months to 2026-06-30$5.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Research and development$m6.1Research and development, Q3 FY2023, three months to 2023-09-30$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure6.1Research and development, Q4 FY2023, three months to 2023-12-31$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047712. Derived: 12-month figure less the 9-month figure.Report this figure5.2Research and development, Q1 FY2024, three months to 2024-03-31$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure5.3Research and development, Q2 FY2024, three months to 2024-06-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure5.2Research and development, Q3 FY2024, three months to 2024-09-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure5.4Research and development, Q4 FY2024, three months to 2024-12-31$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure6.6Research and development, Q1 FY2025, three months to 2025-03-31$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure6.0Research and development, Q2 FY2025, three months to 2025-06-30$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure7.8Research and development, Q3 FY2025, three months to 2025-09-30$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure9.0Research and development, Q4 FY2025, three months to 2025-12-31$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure9.3Research and development, Q1 FY2026, three months to 2026-03-31$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure8.5Research and development, Q2 FY2026, three months to 2026-06-30$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Operating income$m(11.2)Operating income, Q3 FY2023, three months to 2023-09-30−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure(9.7)Operating income, Q4 FY2023, three months to 2023-12-31−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047712. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Operating income, Q1 FY2024, three months to 2024-03-31−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure(9.0)Operating income, Q2 FY2024, three months to 2024-06-30−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure1.2Operating income, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure(8.6)Operating income, Q4 FY2024, three months to 2024-12-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Operating income, Q1 FY2025, three months to 2025-03-31−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure(9.0)Operating income, Q2 FY2025, three months to 2025-06-30−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(10.9)Operating income, Q3 FY2025, three months to 2025-09-30−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure(12.6)Operating income, Q4 FY2025, three months to 2025-12-31−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating income, Q1 FY2026, three months to 2026-03-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure(10.4)Operating income, Q2 FY2026, three months to 2026-06-30−$10.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figurenot reportednot reported0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Net income$m(10.4)Net income, Q3 FY2023, three months to 2023-09-30−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure(8.9)Net income, Q4 FY2023, three months to 2023-12-31−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047712. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Net income, Q1 FY2024, three months to 2024-03-31−$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure(25.3)Net income, Q2 FY2024, three months to 2024-06-30−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure(1.4)Net income, Q3 FY2024, three months to 2024-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure(28.0)Net income, Q4 FY2024, three months to 2024-12-31−$28.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure(27.0)Net income, Q1 FY2025, three months to 2025-03-31−$27.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure39.7Net income, Q2 FY2025, three months to 2025-06-30$39.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(71.6)Net income, Q3 FY2025, three months to 2025-09-30−$71.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure(183)Net income, Q4 FY2025, three months to 2025-12-31−$183.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure(128)Net income, Q1 FY2026, three months to 2026-03-31−$127.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure50.2Net income, Q2 FY2026, three months to 2026-06-30$50.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Diluted EPS$ per share(5.14)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$5.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figurenot reported(4.24)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$4.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure(7.99)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$7.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure(0.44)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figurenot reported(7.43)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$7.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure2.55Diluted EPS, Q2 FY2025, three months to 2025-06-30$2.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(8.36)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$8.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figurenot reported(11.65)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$11.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure(0.41)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Basic EPS$ per share(5.14)Basic EPS, Q3 FY2023, three months to 2023-09-30−$5.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figurenot reported(4.24)Basic EPS, Q1 FY2024, three months to 2024-03-31−$4.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure(7.99)Basic EPS, Q2 FY2024, three months to 2024-06-30−$7.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure(0.44)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figurenot reported(7.43)Basic EPS, Q1 FY2025, three months to 2025-03-31−$7.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure2.55Basic EPS, Q2 FY2025, three months to 2025-06-30$2.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(8.36)Basic EPS, Q3 FY2025, three months to 2025-09-30−$8.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figurenot reported(11.65)Basic EPS, Q1 FY2026, three months to 2026-03-31−$11.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure2.75Basic EPS, Q2 FY2026, three months to 2026-06-30$2.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure

Balance sheet

Cash and equivalents$102.0m, Q2 FY2026
Shareholders' equity−$218.7m, Q2 FY2026
Surrozen, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m34.0Cash and equivalents, Q3 FY2023, at 2023-09-30$34.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure36.0Cash and equivalents, FY2023, at 2023-12-31$36.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-047712.Report this figure27.3Cash and equivalents, Q1 FY2024, at 2024-03-31$27.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure37.8Cash and equivalents, Q2 FY2024, at 2024-06-30$37.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure31.0Cash and equivalents, Q3 FY2024, at 2024-09-30$31.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure34.6Cash and equivalents, FY2024, at 2024-12-31$34.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001193125-26-119818.Report this figure102Cash and equivalents, Q1 FY2025, at 2025-03-31$101.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure90.4Cash and equivalents, Q2 FY2025, at 2025-06-30$90.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure81.3Cash and equivalents, Q3 FY2025, at 2025-09-30$81.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure89.2Cash and equivalents, FY2025, at 2025-12-31$89.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure107Cash and equivalents, Q1 FY2026, at 2026-03-31$106.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure102Cash and equivalents, Q2 FY2026, at 2026-06-30$102.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Current assets$m48.4Current assets, Q3 FY2023, at 2023-09-30$48.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061150.Report this figure41.1Current assets, FY2023, at 2023-12-31$41.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047712.Report this figure32.0Current assets, Q1 FY2024, at 2024-03-31$32.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055706.Report this figure41.6Current assets, Q2 FY2024, at 2024-06-30$41.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095443.Report this figure45.3Current assets, Q3 FY2024, at 2024-09-30$45.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure38.9Current assets, FY2024, at 2024-12-31$38.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001193125-26-119818.Report this figure106Current assets, Q1 FY2025, at 2025-03-31$106.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure94.2Current assets, Q2 FY2025, at 2025-06-30$94.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure85.9Current assets, Q3 FY2025, at 2025-09-30$85.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure91.6Current assets, FY2025, at 2025-12-31$91.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure114Current assets, Q1 FY2026, at 2026-03-31$113.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure109Current assets, Q2 FY2026, at 2026-06-30$109.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Total assets$m54.0Total assets, Q3 FY2023, at 2023-09-30$54.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061150.Report this figure46.1Total assets, FY2023, at 2023-12-31$46.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047712.Report this figure36.7Total assets, Q1 FY2024, at 2024-03-31$36.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055706.Report this figure45.1Total assets, Q2 FY2024, at 2024-06-30$45.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095443.Report this figure48.0Total assets, Q3 FY2024, at 2024-09-30$48.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure48.5Total assets, FY2024, at 2024-12-31$48.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001193125-26-119818.Report this figure115Total assets, Q1 FY2025, at 2025-03-31$114.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure103Total assets, Q2 FY2025, at 2025-06-30$102.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure94.0Total assets, Q3 FY2025, at 2025-09-30$94.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure98.7Total assets, FY2025, at 2025-12-31$98.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure121Total assets, Q1 FY2026, at 2026-03-31$120.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure116Total assets, Q2 FY2026, at 2026-06-30$115.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Current liabilities$m6.7Current liabilities, Q3 FY2023, at 2023-09-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061150.Report this figure7.1Current liabilities, FY2023, at 2023-12-31$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047712.Report this figure6.2Current liabilities, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055706.Report this figure6.0Current liabilities, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095443.Report this figure6.1Current liabilities, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure7.3Current liabilities, FY2024, at 2024-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001193125-26-119818.Report this figure10.6Current liabilities, Q1 FY2025, at 2025-03-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure5.7Current liabilities, Q2 FY2025, at 2025-06-30$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure6.5Current liabilities, Q3 FY2025, at 2025-09-30$6.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure9.9Current liabilities, FY2025, at 2025-12-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure9.6Current liabilities, Q1 FY2026, at 2026-03-31$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure9.0Current liabilities, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Total liabilities$m8.4Total liabilities, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061150.Report this figure8.1Total liabilities, FY2023, at 2023-12-31$8.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047712.Report this figure6.6Total liabilities, Q1 FY2024, at 2024-03-31$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055706.Report this figure39.0Total liabilities, Q2 FY2024, at 2024-06-30$39.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095443.Report this figure42.3Total liabilities, Q3 FY2024, at 2024-09-30$42.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure69.8Total liabilities, FY2024, at 2024-12-31$69.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001193125-26-119818.Report this figure109Total liabilities, Q1 FY2025, at 2025-03-31$109.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure55.6Total liabilities, Q2 FY2025, at 2025-06-30$55.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure118Total liabilities, Q3 FY2025, at 2025-09-30$117.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure286Total liabilities, FY2025, at 2025-12-31$286.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure399Total liabilities, Q1 FY2026, at 2026-03-31$398.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure334Total liabilities, Q2 FY2026, at 2026-06-30$334.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure
Shareholders' equity$m45.5Shareholders' equity, Q3 FY2023, at 2023-09-30$45.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure37.9Shareholders' equity, FY2023, at 2023-12-31$37.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001193125-26-119818.Report this figure30.1Shareholders' equity, Q1 FY2024, at 2024-03-31$30.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure6.1Shareholders' equity, Q2 FY2024, at 2024-06-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure5.7Shareholders' equity, Q3 FY2024, at 2024-09-30$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure(21.4)Shareholders' equity, FY2024, at 2024-12-31−$21.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure5.7Shareholders' equity, Q1 FY2025, at 2025-03-31$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure47.1Shareholders' equity, Q2 FY2025, at 2025-06-30$47.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(23.5)Shareholders' equity, Q3 FY2025, at 2025-09-30−$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure(188)Shareholders' equity, FY2025, at 2025-12-31−$187.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(278)Shareholders' equity, Q1 FY2026, at 2026-03-31−$278.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure(219)Shareholders' equity, Q2 FY2026, at 2026-06-30−$218.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure

Cash flow

Operating cash flow−$7.4m, Q2 FY2026
Capital expenditure$19.0k, Q2 FY2026
Surrozen, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(10.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122318. Derived: 9-month figure less the 6-month figure.Report this figure(7.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-047712. Derived: 12-month figure less the 9-month figure.Report this figure(8.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure(5.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0000950170-25-105847. Derived: 6-month figure less the 3-month figure.Report this figure(6.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272422. Derived: 9-month figure less the 6-month figure.Report this figure3.5Operating cash flow, Q4 FY2024, three months to 2024-12-31$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure(6.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338120. Derived: 6-month figure less the 3-month figure.Report this figure(9.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272422. Derived: 9-month figure less the 6-month figure.Report this figure(5.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure(7.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338120. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122318. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0000950170-25-047712. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0000950170-25-105847. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272422. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338120. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272422. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$59.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-119818. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$120.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338120. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)23.15m, Q2 FY2026
Surrozen, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares35.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3034,968,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061150.Report this figure0.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,998 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055706.Report this figure2.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-302,004,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095443.Report this figure2.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-302,033,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122318.Report this figure0.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-312,083 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0000950170-25-068046.Report this figure0.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,162 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0000950170-25-105847.Report this figure0.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,228 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure0.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,628 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure8.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,541,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure0.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-308,571 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272422.Report this figure0.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,949 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-209179.Report this figure23.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3023,146,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure

Shares outstanding: 11.75mShares outstanding, period not labelled, at 2026-08-0411,753,558 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338120.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.